Fig. 3From: DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinomaSurvival analysis of DPYSL2 in LUAD in the Kaplan–Meier plotter databases and TCGA-LUAD cohort. Kaplan–Meier survival curves of DPYSL2 in overall survival (A) and progression-free survival (B), overall survival analysis of DPYSL2 in TCGA-LUAD cohort analyzed in R (version 4.0.3) (C)Back to article page